Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Visit old site
Home Print this page Email this page Small font size Default font size Increase font size
Users Online: 447
This article has been cited by
1Subcutaneous application of levothyroxine as successful treatment option in a patient with malabsorption
Jan B. Groener,Daniel Lehnhoff,David Piel,Peter P. Nawroth,Jurik Schanz,Gottfried Rudofsky
American Journal of Case Reports.2013;14()48
[DOI]
2Comorbidities, Concomitant Medications, and Diet as Factors Affecting Levothyroxine Therapy: Results of the CONTROL Surveillance Project
Marjorie McMillan,Keith S. Rotenberg,Kevin Vora,Arnold B. Sterman,Lionel Thevathasan,Michael F. Ryan,Munish Mehra,Walter Sandulli
Drugs in R&D.2016;16(1)53
[DOI]
3The Economic Impact of Levothyroxine Dose Adjustments: the CONTROL HE Study
Frank R. Ernst,Peri Barr,Riad Elmor,Walter Sandulli,Lionel Thevathasan,Arnold B. Sterman,Jessica Goldenberg,Kevin Vora
Clinical Drug Investigation.2017;37(1)71
[DOI]
4Retrospective Study of Patients Switched from Tablet Formulations to a Gel Cap Formulation of Levothyroxine: Results of the CONTROL Switch Study
Frank R. Ernst,Walter Sandulli,Riad Elmor,Jennifer Welstead,Arnold B. Sterman,MaryKate Lavan
Drugs in R&D.2017;17(1)103
[DOI]
Feedback
Subscribe

Subscribe this journal
Submit articles
Most popular articles
Joiu us as a reviewer
Email alerts
Recommend this journal